SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000878088-11-000065
Filing Date
2011-08-24
Accepted
2011-08-24 12:06:39
Documents
7
Period of Report
2011-08-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8kaug2011mergerandcommit.htm 8-K 32878
2 AGREEMENT AND PLAN OF MERGER exh21mergeragreement823118k.htm EX-2.1 523892
3 VOTING AGREEMENT exh102votingagreement823118k.htm EX-10.1 31861
4 COMMITMENT LETTER exh102commitmentletter823118.htm EX-10.2 204156
5 GRAPHIC exh102commitmentletter823002.gif GRAPHIC 10138
6 PRESS RELEASE parpressrelease82411for8k2.htm EX-99.1 11879
7 GRAPHIC parpressrelease82411for8k001.gif GRAPHIC 6018
  Complete submission text file 0000878088-11-000065.txt   828528
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10827 | Film No.: 111053289
SIC: 2834 Pharmaceutical Preparations